About this release
This release by Public Health Scotland (PHS) presents performance against the National Endometrial Cancer Quality Performance Indicators (QPIs) in the Cancer QPIs dashboard held within the Scottish Cancer Registry and Intelligence Service (SCRIS).
- There were 739 women diagnosed with Endometrial Cancer in Scotland over the period October 2019 to September 2020. This compares with 814 women in the previous year (October 2018 to September 2019) and 713 in October 2017 to September 2018.
- At Scotland level for October 2019 to September 2020, the target was met in five of the eight indicators with three below target.
- The target for QPI 2 was not met for the third consecutive year. However, the figure is increasing year on year which is a positive trend.
National cancer quality performance indicators have been developed to support continuous quality improvement in cancer care. NHS Boards are required to report these indicators against a clinically agreed indicator specific target as part of the mandatory national cancer quality programme. They have been developed collaboratively by the North Cancer Alliance (external website), South East Scotland Cancer Network (external website), West of Scotland Cancer Network (external website), Healthcare Improvement Scotland (external website) and PHS.
The Cancer QPIs are located within the SCRIS dashboard, thus bringing all the cancer data together in the one place. Access to the Cancer QPIs dashboard is restricted and is accessible via the NHS NSS User Access System (external website).
Endometrial Cancer Indicators
The QPIs titles, measurability specifications and indicated targets detailing the Endometrial Cancer indicators are available from Healthcare Improvement Scotland.
Cancer Quality Performance Indicators
Find more information on cancer QPIs on the Data and intelligence website (external website).
The Scottish Government website has more information on the National Cancer Quality Programme - Scottish Government letter CEL 06 2012.
The next release of this publication will be in September 2024.
If you have an enquiry relating to this publication, please email email@example.com.
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email firstname.lastname@example.org.
To report any issues with a publication, please email email@example.com.